Trending Stock News

$0.24 EPS Expected for BioTelemetry, Inc. (BEAT); Invesco Municipal Opportunity Trust Has 1.78 Sentiment

BioTelemetry, Inc. (NASDAQ:BEAT) Logo

Analysts expect BioTelemetry, Inc. (NASDAQ:BEAT) to report $0.24 EPS on May, 2.They anticipate $0.08 EPS change or 50.00% from last quarter’s $0.16 EPS. BEAT’s profit would be $7.85 million giving it 31.88 P/E if the $0.24 EPS is correct. After having $0.32 EPS previously, BioTelemetry, Inc.’s analysts see -25.00% EPS growth. The stock decreased 3.01% or $0.95 during the last trading session, reaching $30.6. About 262,758 shares traded. BioTelemetry, Inc. (NASDAQ:BEAT) has risen 11.39% since April 9, 2017 and is uptrending. It has underperformed by 0.16% the S&P500.

Invesco Municipal Opportunity Trust (VMO) investors sentiment increased to 1.78 in Q4 2017. It’s up 0.28, from 1.5 in 2017Q3. The ratio has increased, as 41 hedge funds increased or opened new stock positions, while 23 reduced and sold equity positions in Invesco Municipal Opportunity Trust. The hedge funds in our database reported: 6.34 million shares, up from 4.58 million shares in 2017Q3. Also, the number of hedge funds holding Invesco Municipal Opportunity Trust in top ten stock positions decreased from 1 to 0 for a decrease of 1. Sold All: 5 Reduced: 18 Increased: 19 New Position: 22.

BioTelemetry, Inc. provides cardiac monitoring, cardiac monitoring device manufacturing, and centralized cardiac core laboratory services. The company has market cap of $1.00 billion. The firm operates in three divisions: Healthcare, Research, and Technology. It currently has negative earnings. The Healthcare segment focuses on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders.

Investors sentiment decreased to 0.88 in Q4 2017. Its down 0.40, from 1.28 in 2017Q3. It fall, as 47 investors sold BioTelemetry, Inc. shares while 57 reduced holdings. 27 funds opened positions while 65 raised stakes. 27.71 million shares or 8.71% more from 25.49 million shares in 2017Q3 were reported. Mason Street Ltd Liability Corp invested in 7,996 shares or 0.01% of the stock. First Advisors Lp holds 0% or 41,191 shares in its portfolio. 12,429 were accumulated by Alps Advsr. Louisiana State Employees Retirement invested in 0.02% or 13,200 shares. Dubuque Bancorporation And Trust reported 0.02% of its portfolio in BioTelemetry, Inc. (NASDAQ:BEAT). Schwab Charles Inv Management accumulated 140,634 shares. Moreover, Fifth Third Bancorporation has 0% invested in BioTelemetry, Inc. (NASDAQ:BEAT) for 21,674 shares. Credit Suisse Ag reported 0.02% of its portfolio in BioTelemetry, Inc. (NASDAQ:BEAT). Stevens First Principles owns 120 shares for 0% of their portfolio. 10,241 are owned by Metropolitan Life Insur Company Ny. Alliancebernstein Lp stated it has 0% of its portfolio in BioTelemetry, Inc. (NASDAQ:BEAT). Lyon Street Limited Liability Corporation has 379,029 shares for 3.78% of their portfolio. Paloma Prns Management Co holds 0.01% or 30,559 shares. Neuberger Berman Group Incorporated Llc owns 29,541 shares or 0% of their US portfolio. Aperio Ltd Co holds 0% or 22,396 shares.

Among 6 analysts covering BioTelemetry (NASDAQ:BEAT), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. BioTelemetry had 10 analyst reports since July 28, 2015 according to SRatingsIntel. Dougherty & Company maintained the shares of BEAT in report on Tuesday, July 28 with “Buy” rating. On Friday, December 2 the stock rating was initiated by Dougherty & Company with “Buy”. Dougherty & Company maintained BioTelemetry, Inc. (NASDAQ:BEAT) rating on Tuesday, April 11. Dougherty & Company has “Buy” rating and $37.0 target. The stock has “Buy” rating by Sidoti on Tuesday, September 13. As per Thursday, November 30, the company rating was maintained by Raymond James. As per Friday, February 23, the company rating was maintained by Dougherty.

The stock decreased 0.17% or $0.02 during the last trading session, reaching $11.79. About 113,151 shares traded. Invesco Municipal Opportunity Trust (VMO) has declined 10.08% since April 9, 2017 and is downtrending. It has underperformed by 21.63% the S&P500.

Mariner Investment Group Llc holds 0.8% of its portfolio in Invesco Municipal Opportunity Trust for 155,000 shares. Karpus Management Inc. owns 1.06 million shares or 0.61% of their US portfolio. Moreover, Robinson Capital Management Llc has 0.49% invested in the company for 81,400 shares. The Texas-based Fca Corp Tx has invested 0.45% in the stock. Jfs Wealth Advisors Llc, a Pennsylvania-based fund reported 149,353 shares.

BioTelemetry, Inc. (NASDAQ:BEAT) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *